Skip to content

Day Case Laparoscopic Sacrocolpopexy, a New Management

Day-case Laparoscopic Sacrocolpopexy, a Compelling Option in Selected Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03607344
Enrollment
30
Registered
2018-07-31
Start date
2016-01-01
Completion date
2018-06-30
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

Sacrocolpopexy, Day case surgery, Laparoscopic

Brief summary

Facing the stakes of hospital beds, this study assessed day case variant technic of laparoscopic sacrocolpopexy with or without robotic assistant.

Detailed description

Pelvic organ prolapse (POP) is an increasingly common functional disorder which affects approximately 40% of female population. Of these 12% are symptomatic and suffer of physical and emotional distress. 11% will undergo a surgical procedure. Since its introduction by Lane in 1982, Sacrocolpopexy (SCP) became the surgical gold standard for correcting vaginal vault . With minimal invasive approach, SCP had an mean hospitalization time of 3 to 7 days . With rising health care cost and its inherent economic burden, safe and viable options to reduce cost must be sought. Day case surgery has developed rapidly in the USA since the 1970s, and has spread to Europe, especially in Great Britain. But the High Authority of Health in France found a delay in its development. In view of the evolution of surgical and anesthetic techniques, and the low complication rate of SCP, it seemed natural to imagine that this intervention could be done in an ambulatory setting.

Interventions

PROCEDURECohort

Patients undergoing ambulatory laparoscopic sacrocolpopexy

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with symptomatic anterior, apical and/or posterior compartment prolapse * Patients with stage 2 or greater, according to the POP-Q classification * Patients with a body mass index (BMI) \< 30 * Patients with an American Society of Anesthesiologist (ASA) score \< ou = 3.

Exclusion criteria

* Patient with prior history of pelvic cancer surgery and radiotherapy of the pelvis

Design outcomes

Primary

MeasureTime frameDescription
The success rate of outpatient laparoscopic sacrocolpopexy1 month post-operativeThe success rate of outpatient sacrocolpopexy is defined by the number of patients who leaves hospital at the day of surgery

Secondary

MeasureTime frameDescription
Post-operative adverses events1 month post-operativeAdverses events are readmission, hospitalization at another medical hospitalization, complication and if patient has consulted her primary care practitioner or in the emergency department

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026